Development of cAMP signaling underlies tonotopic differentiation of Kv1.1 expression in the avian cochlear nucleus

Technical Summary: Development of cAMP Signaling Underlies Tonotopic Differentiation of Kv1.1 Expression in the Avian Cochlear Nucleus

Problem Statement
Auditory neurons in the nucleus magnocellularis (NM) of the avian cochlear nucleus exhibit tonotopic differentiation, where neurons are systematically arranged by their characteristic frequencies (CFs). A critical aspect of this differentiation is the expression of the Kv1.1 potassium channel, which mediates a low-voltage-activated potassium current. This expression is significantly higher in high-CF (rostromedial) neurons compared to low-CF (caudolateral) neurons, a difference essential for preventing aberrant spike generation and ensuring precise temporal coding. While it is established that afferent activity and intracellular Ca²⁺ elevation drive the upregulation of Kv1.1 around hatching (embryonic day 21–22, E21–22), the downstream signaling mechanisms that confer this spatiotemporal specificity remain elusive. Specifically, since membrane depolarization induces comparable Ca²⁺ elevations in both high- and low-CF neurons in vitro, yet Kv1.1 upregulation occurs only in high-CF neurons, the study seeks to identify the tonotopic-region-specific signaling pathway downstream of Ca²⁺ that mediates this differentiation.

Methodology
The study employed a multimodal approach combining electrophysiology, pharmacology, chemogenetics, and live imaging in the avian cochlear nucleus:

• Electrophysiology: Whole-cell patch-clamp recordings were performed on acute slices to measure Kv1-mediated potassium currents in high- and low-CF neurons at various developmental stages (E18, E21, and posthatch day 5, P5).
• Chemogenetics: In ovo electroporation was used to express specific tools in NM neurons:
  • PSAM4-5HT3-LC: A ligand-gated cation channel activated by PSEM89S to induce membrane depolarization and assess activity-dependent mechanisms.
  • Gs-DREADD: A Gs-coupled designer receptor activated by deschloroclozapine (DCZ) to elevate cAMP levels.
  • PDEcat: A catalytic domain of cAMP-specific phosphodiesterase (PDE4D3) overexpressed via a Tet-On system to degrade intracellular cAMP.
• Pharmacology: Organotypic slice cultures were treated with inhibitors (e.g., 2',5'-ddAdo for adenylate cyclase, KT5720 for PKA, Bis-I for PKC, TATCN21 for CaMKII) and activators (forskolin for AC, IBMX for PDE inhibition) to dissect the signaling cascade.
• Live Imaging: Genetically encoded fluorescent cAMP sensors (G-Flamp1) and volume markers (mKate2) were expressed to optically monitor cAMP dynamics in response to pharmacological manipulation (forskolin, IBMX, dipyridamole) in acute slices.
• Immunohistochemistry: Kv1.1 protein localization was analyzed to distinguish between membranous and cytosolic fractions.

Key Contributions and Results

1. Identification of cAMP as the Key Downstream Mediator:
   Pharmacological screening in slice cultures revealed that the Ca²⁺-dependent increase in Kv1 current is abolished by inhibiting adenylate cyclase (AC) or protein kinase A (PKA), but not protein kinase C (PKC). Conversely, elevating cAMP levels via forskolin (AC activator) or IBMX (PDE inhibitor) significantly amplified Kv1 currents. This establishes cAMP signaling as the critical downstream effector of Ca²⁺ for Kv1.1 upregulation.

2. Mechanism of Surface Localization:
   In vivo overexpression of PDEcat (to lower cAMP) suppressed the developmental increase in Kv1 current and eliminated the membranous fraction of Kv1.1 protein in high-CF neurons around hatching. Conversely, chemogenetic elevation of cAMP (via Gs-DREADD) increased Kv1 currents specifically in high-CF neurons at E21. These findings indicate that cAMP signaling facilitates the insertion of Kv1.1 channels into the plasma membrane rather than solely regulating transcription or translation, as cytosolic Kv1.1 levels actually increased when cAMP was suppressed.

3. Tonotopic and Developmental Maturation of cAMP Production:
   Live cAMP imaging revealed a specific developmental shift in high-CF neurons. While basal cAMP levels did not differ significantly between high- and low-CF neurons, the capacity to produce cAMP upon stimulation (via forskolin) increased markedly in high-CF neurons between E18 and E21–P2. In contrast, the capacity for cAMP degradation (mediated by PDE) remained relatively constant across regions and ages. This suggests that the maturation of AC activity is the limiting factor that drives the spatiotemporal specificity of Kv1.1 upregulation.

4. Independence from Afferent Input for AC Maturation:
   Chemogenetic depolarization of neurons at E18 failed to increase Kv1 currents, even in high-CF neurons, suggesting that the machinery for activity-dependent Kv1.1 upregulation is not yet mature at this stage. Furthermore, since high-CF neurons have higher auditory thresholds than low-CF neurons, the authors conclude that the maturation of AC activity is likely driven by an intrinsic, tonotopic-region-specific genetic program (potentially linked to rhombomeric origin) rather than being solely a consequence of afferent input intensity.

Significance
The paper claims that the tonotopic differentiation of Kv1.1 expression in the avian cochlear nucleus is underpinned by the region-specific maturation of cAMP signaling. Specifically, the increased capacity for Ca²⁺-dependent cAMP production in high-CF neurons around hatching acts as a spatiotemporal switch, enabling the activity-dependent upregulation of Kv1.1 surface expression. This mechanism ensures that high-CF neurons acquire the necessary biophysical properties (large Kv1 currents) for high-fidelity temporal coding earlier and more robustly than low-CF neurons. The study highlights that neuronal differentiation involves not just the expression of ion channels but also the maturation of the intracellular signaling machinery that regulates them, providing a fundamental insight into how auditory circuits achieve precise frequency-specific processing.